ArticleCytoskeleton (Hoboken, N.J.)2026
The Role of Runx2 in Microtubule Dynamics and Its Effects on Osteoblast Migration.
Article in Cytoskeleton (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The migration of osteoblasts (OBs) is crucial for bone formation, remodeling, and healing. This requires the coordinated activity of cytoskeletal components, including microtubules (MTs). MTs complement actin filaments by regulating focal adhesion turnover and facilitating the delivery of essential proteins and cargo. However, the roles and regulation of MTs during OB migration remain unclear. Previous studies show that Runt-related transcription factor-2 (Runx2), a master regulator of OB differentiation, promotes MT stability in pathological contexts, such as breast cancer metastasis. In this study, we investigated the effects of Runx2 deficiency on OB migration and MT dynamics using wild-type and Runx2-deficient calvarial OBs. To assess MT function more precisely, we treated cells with microtubule-targeting agents (MTAs) that differentially affect dynamic and stable MT populations. Measurements of K40 on α-tubulins were utilized to mark longer-lived and stable MTs. Our findings revealed distinct differences in the dynamics and regulation of MTs respective to Runx2 status. Runx2-deficient OBs demonstrated increased levels of acetyl-α-tub as measured by whole cell lysate. During nutrient stress, such as glucose starvation, Runx2-deficient OBs exhibit a more rapid increase in acetyl-α-tub. However, these cells are also more sensitive to losing this stable MT fraction, notably upon exposure to MTA vinblastine. Confocal microscopy of the enzymes regulating acetyl-α-tub, ATAT1 and HDAC6, reveals striking differences in subcellular localization and colocalization to α-tubulins. Interestingly, wound-healing assays suggest Runx2-deficient OBs possess enhanced migratory capacity under both basal conditions and following MT disruption. Altogether, these findings uncover a novel role for Runx2 in regulating MT dynamics and suggest that, in specific contexts, Runx2 may suppress OB migration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.